Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  sipuleucel-T
Find trials that include:  Any drugs shown
Results 1-7 of 7 for your search:
Start Over
Sipuleucel-T with or without Indoximod in Treating Patients with Metastatic Hormone-Resistant Prostate Cancer
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 2011LS109, NCI-2012-00923, 1202M10704, NCT01560923
Sipuleucel-T with or without DNA Vaccine Therapy in Treating Patients with Hormone-Resistant Metastatic Prostate Cancer
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: CO11816, NCI-2012-02026, NCT01706458
Sipuleucel-T With or Without Radiation Therapy in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 12367, NCI-2013-00542, 097472, NCT01807065
Sipuleucel-T with or without Tasquinimod in Treating Patients with Metastatic Hormone-Resistant Prostate Cancer
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: I 250813, NCI-2014-01184, NCT02159950
Immediate or Delayed Ipilimumab after Sipuleucel-T Treatment in Treating Patients with Metastatic Hormone-Resistant Prostate Cancer
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 12557, NCI-2014-00318, 079730, CC#12557, NCT01804465
Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T
Phase: No phase specified
Type: Biomarker/Laboratory analysis
Age: 18 and over
Trial IDs: P11-4, NCI-2015-00139, NCT01727154
Radiation Therapy in Treating Patients with Metastatic Hormone-Resistant Prostate Cancer Receiving Sipuleucel-T
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: I 223912, NCI-2013-00633, NCT01833208
Start Over